Rxwire
In the news · 48h FDA 39 Eli Lilly 19 Roche 9 Merck & Co. (MSD) 8 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Novo Nordisk 3
Approvals & regulatory · first seen yesterday, updated yesterday

Compass Therapeutics downgraded at Wedbush as FDA seeks additional trial for lead asset

1 outlet FDA

Coverage 1 article · 1 outlet

  1. Seeking Alpha Healthcare
    Compass Therapeutics downgraded at Wedbush as FDA seeks additional trial for lead asset